Skip to main content

Day: September 16, 2020

Apollo Commercial Real Estate Finance, Inc. Declares Quarterly Common Stock Dividend

NEW YORK, Sept. 16, 2020 (GLOBE NEWSWIRE) — Apollo Commercial Real Estate Finance, Inc. (the “Company”) (NYSE:ARI) today announced the Board of Directors declared a dividend of $0.35 per share of common stock, which is payable on October 15, 2020 to common stockholders of record on September 30, 2020. About Apollo Commercial Real Estate Finance, Inc.Apollo Commercial Real Estate Finance, Inc. (NYSE: ARI) is a real estate investment trust that primarily originates, acquires, invests in and manages performing commercial first mortgage loans, subordinate financings and other commercial real estate-related debt investments.  The Company is externally managed and advised by ACREFI Management, LLC, a Delaware limited liability company and an indirect subsidiary of Apollo Global Management, Inc., a leading global alternative investment...

Continue reading

Orchid Island Capital Announces September 2020 Monthly Dividend and August 31, 2020 RMBS Portfolio Characteristics

September 2020 Monthly Dividend of $0.065 Per Share of Common StockRMBS Portfolio Characteristics as of August 31, 2020Next Dividend Announcement Expected October 14, 2020VERO BEACH, Fla., Sept. 16, 2020 (GLOBE NEWSWIRE) — Orchid Island Capital, Inc. (the “Company”) (NYSE:ORC) announced today that the Board of Directors (the “Board”) declared a monthly cash dividend for the month of September 2020. The dividend of $0.065 per share will be paid October 28, 2020, to holders of record of the Company’s common stock on September 30, 2020, with an ex-dividend date of September 29, 2020.  The Company plans on announcing its next common stock dividend after the Board’s meeting on October 14, 2020.The Company intends to make regular monthly cash distributions to its holders of common stock. In order to qualify as a real estate investment...

Continue reading

Firm Capital American Realty Partners Trust Announces the Closing of a 50% Interest in a 235 Unit, Multi-Family Residential Building for $37.5 Million in the Washington D.C. Metro Area

All amounts are in US Dollars unless otherwise stated.TORONTO, Sept. 16, 2020 (GLOBE NEWSWIRE) — Firm Capital American Realty Partners Trust (the “Trust”), (TSXV: FCA.U), (TSXV: FCA) is pleased to announce it has entered into a joint venture agreement with an unrelated third party to acquire a $37.5 million multi-family residential property located in the Washington D.C. Metro Area.North Pointe Apartments (“North Pointe” or the “Property”) is a 235-unit, multi-family residential property located in Hyattsville, Maryland. Hyattsville, MD is located within the Washington D.C. Metro Area and is in close proximity to the Trust’s Brentwood, MD joint venture. The joint venture is purchasing the property for $37.5 million or approximately $159,575 per unit ($217 per square foot), representing a 5.7% capitalization rate. The Property is...

Continue reading

The Pennant Group Acquires Texas Home Health Agency

EAGLE, Idaho, Sept. 16, 2020 (GLOBE NEWSWIRE) — The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced that it has acquired the assets of CMS Home Health Care, which has locations in Brownwood and Coleman, Texas. The acquisition was effective September 16, 2020.Danny Walker, Pennant’s Chief Executive Officer, commented, “With sister operations in Abilene, Austin, and Dallas, this off-market acquisition is an excellent strategic fit for our burgeoning Texas portfolio of home health and hospice operations. Our local leaders, supported by dedicated field and service center resources, continue to source and cultivate new opportunities for growth while navigating dynamic operating environments in their local communities.”“The team...

Continue reading

iLOOKABOUT Executes Asset Purchase Agreement with Apex Software

TORONTO, Sept. 16, 2020 (GLOBE NEWSWIRE) — iLOOKABOUT Corp. (TSXV:ILA; OTCQB:ILATF) (“ILA” or “the Company”) announced that, further to the news release issued August 28, 2020, with respect to ILA’s proposed transaction with Starcap Marketing, LLC (d.b.a. Apex Software) (“Apex”), ILA has entered into an asset purchase agreement (“APA”) with Apex for the acquisition by ILA of all the operating assets of Apex (the “Transaction”). Consideration for the Transaction will be in the form of $4,800,000 (USD) cash due on closing of the Transaction, $400,000 (USD) due on the first anniversary of the closing as an indemnity holdback, and $400,000 (USD) of ILA stock to be calculated using a defined value of $0.15 (CAD) (subject to any required pricing adjustments). As at the date hereof, the current working capital position of Apex (including...

Continue reading

Devon Energy Announces Fourth-Quarter 2020 Cash Dividend for Common Stockholders

OKLAHOMA CITY, Sept. 16, 2020 (GLOBE NEWSWIRE) — Devon Energy Corp. (NYSE: DVN) announced today that its board of directors has declared a quarterly cash dividend on Devon’s common stock for the fourth quarter of 2020. The dividend is payable on Dec. 30, 2020, at a rate of $0.11 per share based on a record date of Dec. 11, 2020.ABOUT DEVON ENERGYDevon Energy is a leading independent energy company engaged in finding and producing oil and natural gas. Based in Oklahoma City and included in the S&P 500, Devon operates in several of the most prolific oil and natural gas plays in the U.S. with an emphasis on achieving strong corporate-level returns and capital-efficient cash-flow growth. For more information, please visit www.devonenergy.com.

Continue reading

PRA Health Sciences宣布任命新董事

北卡罗来纳州罗利, Sept. 17, 2020 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc.(NASDAQ:PRAH)今天宣布任命Glen Stettin为公司董事,任命自2020年9月14日起生效。“我们很高兴Glen将加入我们的董事会。Stettin博士作为医生和高管广泛参与医疗保健领域的工作,他在创新、数据、分析、技术和综合健康解决方案方面的经验将为董事会提供宝贵的见解,帮助我们继续重塑临床研究,使其更易于为患者所用。”PRA Health Sciences, Inc.总裁、首席执行官兼董事会主席Colin Shannon表示。Stettin博士是Cigna Corporation旗下Express Scripts & Cigna Services的高级副总裁兼首席创新官,负责新临床解决方案和数据、分析以及平台即服务领域的研发、医患体验、产品开发和管理。在此之前,Stettin博士曾担任Express Scripts高级副总裁兼首席创新官,该公司于2018年被Cigna Corporation收购。Stettin博士在2012年4月Express Scripts与Medco Health Solutions, Inc.合并时加入了该公司。在Medco工作的17年中,他曾担任临床、运营、技术和产品组织领域的领导职务。Stettin博士拥有理海大学和宾夕法尼亚州医学院的学士及医学专业学位。他在加利福尼亚州大学旧金山分校完成了内科住院医师培训,还曾在Moffitt-Long Hospital担任内科住院总医师,并在加州大学旧金山分校和斯坦福大学任心脏科研究医师和罗伯特·伍德·约翰逊基金会临床学者。关于PRA Health Sciences按营业收入计,PRA Health Sciences是世界最大的全球合同研究机构之一,为生物技术和制药行业提供外包临床研发和数据解决方案服务。PRA全球临床研发平台遍及北美、欧洲、亚洲、拉丁美洲、南非、澳大利亚和中东,办公机构达到75个以上,全球员工超过17500人。2000年以来,PRA已参与了世界各地约4000项临床试验。此外,PRA还参与了众多关键性或支持性试验,超过95种产品由此获得了美国食品药品管理局和国际监管机构批准。要了解有关PRA的更多信息,请访问www.prahs.com。投资者关系咨询:InvestorRelations@prahs.com媒体咨询:Laurie...

Continue reading

PRA Health Sciences 宣佈委任新董事

北卡羅萊納州羅利, Sept. 17, 2020 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ:PRAH) 今天宣佈委任 Glenn Stettin 為公司董事會成員,並於 2020 年 9 月 14 日生效。PRA health Sciences 董事會主席兼行政總裁 Colin Shannon 說:「我們很高興看到 Glen 加入我們的董事會。Stettin 醫生作為一名醫生及行政人員涉獵廣泛的醫療保健領域,在創新、數據、分析、技術及綜合健康解決方案方面擁有豐富經驗,將為董事會提供寶貴的見解,協助我們繼續重新發明臨床研究,讓患者更容易參與。」Stettin 醫生任職於 Cigna Corporation 旗下的 Express Scripts & Cigna Services,擔任高級副總裁兼創新總裁,負責研發、患者及醫生體驗、產品開發及管理,專注於新的臨床解決方案及數據、分析及平台即服務。此前,Stettin 醫生在 Express Scripts 擔任高級副總裁兼創新總裁,該公司於 2018 年被 Cigna Corporation 收購。Express Scripts 與 Medco Health Solutions, Inc. 於 2012 年 4 月合併,Stettin 醫生亦是在當時加入 Express Scripts。在為 Medco 效力的 17 年期間,他在臨床、營運、技術及產品組織中擔任領導職務。Stettin 醫生獲得理海大學和賓夕法尼亞醫學院的學士及醫學學位。他在加州大學三藩市分校完成內科醫生駐院課程,還擔任 Moffitt-Long Hospital 的首席駐院醫生及心臟科專家,也是加州大學三藩市分校及斯坦福大學 Robert Wood Johnson Foundation 臨床學者。關於 PRA Health Sciences 公司PRA Health...

Continue reading

PRA Health Sciences annonce la nomination d’un nouveau directeur

RALEIGH, Caroline du Nord, 16 sept. 2020 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ : PRAH) a annoncé aujourd’hui la nomination de Glen Stettin, M.D., au conseil d’administration de la société, à compter du 14 septembre 2020.« Nous sommes ravis que Glen rejoigne notre conseil d’administration. Au vu de son implication généralisée dans le domaine des soins de santé en tant que médecin et cadre, l’expérience du Dr Stettin en matière d’innovation, de données, d’analyse, de technologie et de solutions de santé intégrées fournira au conseil d’administration des renseignements précieux alors que nous continuons à réinventer la recherche clinique et à la rendre plus accessible aux patients », a déclaré Colin Shannon, président-directeur général et président du conseil d’administration...

Continue reading

PRA Health Sciences gibt Ernennung eines neuen Verwaltungsratsmitglieds bekannt

RALEIGH, North Carolina, Sept. 16, 2020 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ: PRAH) hat heute die Ernennung von Dr. Glen Stettin zum Verwaltungsratsmitglied des Unternehmens mit Wirkung zum 14. September 2020 bekanntgegeben.„Wir freuen uns sehr, dass Dr. Stettin Mitglied unseres Verwaltungsrats wird. Dr. Stettins Erfahrung in den Bereichen Innovation, Daten, Analytik, Technologie und integrierte Gesundheitslösungen wird dem Verwaltungsrat wertvolle Erkenntnisse liefern, während wir die klinische Forschung weiterhin neu erfinden und sie für Patienten zugänglicher machen“, so Colin Shannon, President, Chief Executive Officer und Verwaltungsratsvorsitzender von PRA Health Sciences, Inc.Dr. Stettin ist Senior Vice President und Chief Innovation Officer bei Express Scripts & Cigna Services, einem Geschäftsbereich...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.